Browsing by Author "Nervi Nattero, Bruno"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
- ItemAdmission of Hematopoietic Cell Transplantation Patients to the Intensive Care Unit at the Pontificia Universidad Catolica de Chile Hospital(2015) Escobar, K.; Rojas, P.; Ernst Diaz, Daniel Matias; Bertín Cortes Monroy, Pablo; Nervi Nattero, Bruno; Jara, V.; Garcia, M.; Ocqueteau Tachini, Mauricio; Sarmiento Maldonado, Mauricio; Ramirez, P.
- ItemDifferential Effects of a Telemonitoring Platform in the Development of Chemotherapy-Associated Toxicity: A Randomized Trial Protocol(2024) Martínez, Felipe; Taramasco, Carla; Espinoza Sepúlveda, Manuel Antonio; Acevedo, Johanna; Goic Boroevic, Carolina; Nervi Nattero, BrunoChemotherapy requires careful monitoring, but traditional follow-up approaches face significant challenges that were highlighted by the COVID-19 pandemic. Hence, exploration into telemonitoring as an alternative emerged. The objective is to assess the impact of a telemonitoring platform that provides clinical data to physicians overseeing solid tumor patients, aiming to enhance the care experience. The methodology outlines a parallel-group randomized clinical trial involving recently diagnosed patients with solid carcinomas preparing for curative intent chemotherapy. Eligible adult patients diagnosed with specific carcinoma types and proficient in Spanish, possessing smartphones, will be invited to participate. They will be randomized using concealed allocation sequences into two groups: one utilizing a specialized smartphone application called Contigo for monitoring chemotherapy toxicity symptoms and accessing educational content, while the other receives standard care. Primary outcome assessment involves patient experience during chemotherapy using a standardized questionnaire. Secondary outcomes include evaluating severe chemotherapy-associated toxicity, assessing quality of life, and determining user satisfaction with the application. The research will adhere to intention-to-treat principles. This study has been registered at ClinicalTrials.gov (NCT06077123)
- ItemRegorafenib adjusted dose for Chilean patients with chemoresistant metastatic colorectal cancer: a case series(2018) Leal, José Luis; Briones, Juan; Herrera, María Elisa; Müller, Bettina; Nervi Nattero, Bruno; Mondaca Contreras, Sebastián Patricio
- ItemThe immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses(2013) Duran Aniotz, C.; Segal, G.; Salazar, L.; Pereda, C.; Falcon, C.; Tempio, F.; Aguilera, R.; Nervi Nattero, Bruno
- ItemTratamiento endovascular de fístula aorto esofágica secundaria a cáncer de esófago. Caso clínico(2013) Bergoeing Reid, Michel Paul; Mertens Martín, Renato; Mariné M., Leopoldo; Valdés Echeñique, José Francisco; Kramer, Albrecht; Nervi Nattero, Bruno; Borghero Ríos, Yerko Orestes